Chronic diseases, such as heart disease, diabetes, stroke, and obesity, are the leading causes of death across the region, and these diseases account for the largest share of the country's health care cost. According to CDC, in 2018, ~9% of the total population had diabetes, and it is the major cause of lower-limb amputation and kidney failure in the US. Further, the report also suggests that more than 1.5 million American population are diagnosed with diabetes in the US every year.
According to the American College of Cardiology Foundation, in 2018, CHD was the major cause of death due to cardiovascular disease (CVD), followed by stroke, high BP, heart failure, and other CVDs, with a contribution share of 16.8%, 9.4%, 9.0%, and 17.9% respectively. By 2035, nearly 130 million adults in the US are feared to have CVD. Thus, the rising geriatric population and related chronic disorders are expected to push the sales of healthcare virtual assistants devices, thus propelling the growth of the North America healthcare virtual assistants devices market during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the healthcare virtual assistants market at a promising CAGR during the forecast period.
The North America healthcare virtual assistants market is segmented into component and end user. Based on component, the market is segmented into speech recognition, text-to-speech, and voice recognition. Based on end user, the market is segmented into providers, payers, and others. Geographically, the market is segmented into the US, Canada, and Mexico.